Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q16581
UPID:
C3AR_HUMAN
Alternative names:
-
Alternative UPACC:
Q16581; O43771; Q92868
Background:
The C3a anaphylatoxin chemotactic receptor plays a pivotal role in immune responses by acting as a receptor for the chemotactic and inflammatory peptide anaphylatoxin C3a. It is instrumental in stimulating chemotaxis, granule enzyme release, and superoxide anion production, which are crucial processes in the body's defense mechanism.
Therapeutic significance:
Understanding the role of C3a anaphylatoxin chemotactic receptor could open doors to potential therapeutic strategies. Its involvement in key immune responses highlights its potential as a target for developing treatments aimed at modulating immune functions.